Hepatitis C virus infection is associated with a variety of extrahepatic disorders such as membrano-proliferative glomerulonephritis, which is generally due to cryoglobulinemia.
Setting
We describe the case of one liver transplant recipient who received antiviral therapy (subcutaneous administration of peg-IFN-alpha-2a 180 mcg weekly and oral ribavirin 200 mg thrice a day) for HCV-related membrano-proliferative glomerulonephritis. He presented normal kidney function, non-nephrotic proteinuria (2 g/24 h) and mild hematuria.
Results
Urinary abnormalities disappeared within a few weeks after the initiation of antiviral therapy; however, combination antiviral therapy was not able to obtain viral clearance. After 11 months, IFN-therapy was interrupted and the patient continued low-dose ribavirin monotherapy (200 mg once per day) for one additional year- remission of proteinuria (<0.3 g/24 h) and hematuria persisted with intact kidney function. Although other mechanisms cannot be excluded, we suggest that ribavirin therapy was critically implicated in the remission of urinary abnormalities in our patient. The existing literature on the association between HCV-associated glomerulonephritis and therapy with ribavirin is reviewed.
Conclusions
Antiviral therapy may be effective in patients with HCV-induced glomerulonephritis. Further evidence is needed to evaluate efficacy and safety of ribavirin monotherapy for HCV-related glomerulonephritis.
LauerG.M., WalkerB.D.Hepatitis C virus infection. N Engl J Med.2001; 345(1): 41–52.
2.
FabriziF., ColucciP., PonticelliC., LocatelliF.Kidney and liver involvement in cryoglobulinemia. Semin Nephrol.2002; 22(4): 309–318.
3.
JohnsonR.J., WillsonR., YamabeH.Renal manifestations of hepatitis C virus infection. Kidney Int.1994; 46(5): 1255–1263.
4.
El-SeragH.B., HampelH., YehC., RabeneckL.Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology.2002; 36(6): 1439–1445.
5.
National Kidney Foundation. Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int.2008; 73(Suppl 109): 1–99. Accessed October 12, 2012.
6.
FabriziF., LunghiG., MessaP.G., MartinP.Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol.2008; 21(6): 813–825.
PericoN., CattaneoD., BikbovB., RemuzziG.Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol.2009; 4(1): 207–220.
9.
CoroneosE., PetrusevskaG., VargheseF., TruongL.D.Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis.1996; 28(6): 888–892.
10.
OhtaS., YokoyamaH., WadaT.Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis.1999; 33(6): 1040–1048.
11.
DimitrovY., HeibelF., MarcellinL., ChantrelF., MoulinB., HannedoucheT.Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrol Dial Transplant.1997; 12(1): 200–203.
12.
PascualM., ThadhaniR., ChungR.T.Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation.1997; 64(7): 1073–1076.
13.
BaidS., CosimiA.B., Tolkoff-RubinN., ColvinR.B., WilliamsW.W., PascualM.Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation.2000; 70(2): 255–261.
MontalbanoM., PasuloL., SonzogniA., RemuzziG., ColledanM., StrazzaboscoM.Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. J Clin Gastroenterol.2007; 41(2): 216–220.
SikanetaT., WilliamsW.W., ChungR.T., CosimiA.B., PascualA.M.Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation. Transplantation.2002; 74(12): 1767–1768.
18.
JohnsonR.J., GretchD.R., CouserW.G.Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int.1994; 46(6): 1700–1704.
19.
MisianiR., BellavitaP., FeniliD.Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med.1994; 330(11): 751–756.
20.
D'AmicoG.Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int.1998; 54(2): 650–671.
21.
Al-WakeelJ., MitwalliA., TarifN., Al-MohayaS., MalikG., KhalilM.Role of interferon-alpha in the treatment of primary glomerulonephritis. Am J Kidney Dis.1999; 33(6): 1142–1146.
22.
BruchfeldA., LindahlK., StåhleL., SöderbergM., SchvarczR.Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant.2003; 18(8): 1573–1580.
23.
RossiP., BertaniT., BaioP.Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int.2003; 63(6): 2236–2241.
24.
AlricL., PlaisierE., ThébaultS.Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis.2004; 43(4): 617–623.
25.
GariniG., AllegriL., LannuzzellaF., VaglioA., BuzioC.HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies. Acta Biomed.2007; 78(1): 51–59.
26.
RoccatelloD., FornasieriA., GiachinoO.Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis.2007; 49(1): 69–82.
27.
AbbasG., HussainS., ShafiT.Effect of antiviral therapy on hepatitis C virus related glomerulopathy. Saudi J Kidney Dis Transpl.2008; 19(5): 775–780.
PattersonJ.L., Fernandez-LarssonR.Molecular mechanisms of action of ribavirin. Rev Infect Dis.1990; 12(6): 1139–1146.
30.
LauJ.Y., TamR.C., LiangT.J., HongZ.Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology.2002; 35(5): 1002–1009.
31.
PhamH.P., FérayC., SamuelD.Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int.1998; 54(4): 1311–1319.
32.
HuS.L., JaberB.L.Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy. Clin Nephrol.2005; 63(1): 41–45.
33.
KamarN., Sandres-SauneK., SelvesJ.Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. Am J Kidney Dis.2003; 42(1): 184–192.
34.
DurandJ.M., CacoubP., Lunel-FabianiF.Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol.1998; 25(6): 1115–1117.
